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A b s t r a c t  
Methoxy poly(ethylene glycol)-b-poly(D,L-lactide-co-glycolide-co-e-caprolactone) (MPEG-b-
PDLLGCL) amphiphilic diblock copolymers were synthesized and used as nanosphere matrices. 
The drug-loaded nanospheres were prepared by the modified-spontaneous emulsification diffusion 
method without any emulsifiers for controlled drug delivery of poorly water-soluble model drug, 
indomethacin. Effect of DLL/G/CL ratio on nanoparticle and drug release characteristics was 
evaluated. The resultant drug-loaded nanospheres with average size in range of 126 – 134 nm had 
spherical in shape and smooth in surface. The drug entrapped inside the nanospheres had 
amorphous state. Drug loading efficiency was not found to be influenced by the DLL/G/CL ratio. The 
drug release profiles exhibited biphasic with a fast release followed by a slow release. The amounts 
of drug release increased when the G and CL units were incorporated in the polyester blocks. This 
indicates that MPEG-b-PDLLGCL nanospheres might be useful candidate as sustained drug carriers 
for poorly water-soluble drugs. 
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Introduction 
Biodegradable polyesters including poly(D,L-lactide) (PDLL), 
polyglycolide (PG), poly(e-caprolactone) (PCL) and their 
copolymers have widely investigated for use in biomedical and 
pharmaceutical applications due to their biocompatibility and 
biodegradability [1-4]. Amphiphilic diblock copolymers composed 
of methoxy poly(ethylene glycol) (MPEG) and polyesters such as 
poly(D,L-lactide) (PDLL) [5-7], poly(e-caprolactone) (PCL) [8], 
polyglycolide (PG) [9] and their copolymers [10, 11] have been 
synthesized to attain versatile biodegradable polymers having 
more water-absorbing capacity because of the inclusion of 
hydrophilic MPEG segments within the relative hydrophobic 
polyester segments. These diblock copolymers have been used 
for the preparation of drug-loaded nanoparticles [8, 9]. Their 
nanoparticles have shown potential as drug delivery systems 
because of their small sizes that improving circulation times in the 
body and creates more available routes of administration than do 
microparticles, which are rapidly cleared by the reticulo-
endothelial tissues. Most of the previous works have concentrated 
on diblock copolymer nanoparticles consisting of MPEG and 
homo-/copolyester blocks. However, the diblock copolymer 
nanoparticles comprising MPEG and PDLLGCL blocks for 
controlled drug release applications have not been reported.  
The modified-spontaneous emulsification-solvent diffusion method 
(modified-SESD method) for the preparing emulsifier-free 
nanoparticles of hydrophilic-hydrophobic diblock copolymer was 
first proposed as previously described [12]. MPEG-b-poly(D,L-
lactide) was dissolved in volatile water-miscible organic solvents 
with lower toxicity, acetone and ethanol. Higher energy apparatus, 
such as a homogenizer or a sonicator (usually applied in larger 
scale preparation of polymer nanoparticles), was not used for this 
technique.  
In our previous work [13], nanoparticles of MPEG-b-PDLLGCL 
copolymers have been prepared and characterized. The 
nanoparticles of diblock copolymers with varying DLL/G/CL ratios 
have been investigated and their chemical structure-particle 
character relationships are discussed. The aims of present study 
were to prepare emulsifier-free drug-loaded MPEG-b-PDLLGCL 
nanospheres by the modified-SESD method and to investigate the 
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influence of DLL/G/CL ratio on the drug-loaded nanosphere 
characteristics and drug release behaviors. Indomethacin was 
used as a poorly-water soluble model drug.  
 
Materials and Methods 
Materials  
Methoxy poly(ethylene glycol) (MPEG) with a molecular weight of 
5,000 g/mol (Fluka, Germany) was dried at 120 °C under reduced 
pressure for 4 h before use. D,L-lactide (DLL) and glycolide (G) 
monomers were synthesized by well established procedures from 
D,L-lactic acid (90%, Fluka, Switzerland) and glycolic acid (99%, 
Acros, USA), respectively. Each was purified by repeated re-
crystallization from distilled ethyl acetate. e-Caprolactone (CL) 
monomer (99%, Acro, USA) was purified by drying with CaH2 
followed by distillation under reduced pressure before storage 
over molecular sieves in a refrigerator. Stannous octoate 
(Sn(Oct)2, 95%, Sigma, USA) and indomethacin (98%, Sigma) 
were used without further purification. Acetone (Merck, Germany) 
and ethanol (Merck, Germany) in analytical grade were used. 
Synthesis and Characterization of Diblock 
Copolymers 
MPEG-b-PDLLGCL with DLL/G/CL feed ratios of 100/0/0, 80/20/0 
and 80/15/5 mol% were synthesized by the ring-opening 
polymerization in bulk at 130 °C for 24 h under nitrogen 
atmosphere [14]. The PDLLGCL block length with approximately 
60,000 g/mol was synthesized to attach the MPEG block. MPEG 
and Sn(Oct)2 were used as the initiating system. The Sn(Oct)2 
concentration was kept constant at 0.02 mol%. The as-
polymerized copolymers were purified by dissolving in chloroform 
before precipitating in cool n-hexane. They were then dried to 
constant weight in a vacuum oven at room temperature. The 
chemical composition and number-average molecular weight (
nM ) were determined using 1H-NMR spectrometer (Bruker 
Advanced DPX 300). CDCl3 was used as a solvent at room 
temperature, and tetramethysilane was used as the internal 
standard. The thermal properties of copolymers were 
characterized using a differential scanning calorimeter (DSC, 
Perkin-Elmer Pyris Diamond) at heating rate of 10 °C/min under 
helium flow.  
Preparation of Drug-loaded Nanospheres 
Indomethacin-loaded nanospheres were prepared by the modified 
SESD method without any emulsifiers [13]. Briefly, indomethacin 
(4 mg) and copolymer (36 mg) were dissolved in 2 mL of 1/1 (v/v) 
acetone/ethanol mixture. The solution was added drop-wise into 
16 mL of deionized water under magnetic stirring. The 
nanospheres were immediately formed after solvent diffusion. The 
organic solvents were then evaporated at room temperature for 6 
h in a fume hood. The resulting nanosphere suspension was 
centrifuged for 1 h at 12,000 rpm at 4 °C. The supernatant was 
carefully discarded and the pellet was re-suspended in water. The 
final nanosphere suspension volume was adjusted to 16 mL with 
deionized water. The dried nanospheres were obtained by 
centrifugation at 12,000 rpm for 1 h at 4 °C before freeze-drying 
for 48 h.  
 
Characterization of Drug-loaded Nanospheres 
Morphology of the nanospheres was investigated by a 
transmission electron microscope (TEM, JEOL JEM 1230). For 
TEM analysis, a drop of nanosphere suspension was placed on a 
formvar film coated on the copper grid. The specimen on the 
copper grid did not stain. Average particle size and size 
distribution of the drug-loaded nanospheres were determined from 
the nanosphere susprensions by a light-scattering particle size 
analyzer (Coulter LS230) at 25 °C. Thermal properties of the 
dried nanospheres were measured by DSC as described above. 
Theoretical drug loading content (DLCtheoretical), actual drug 
loading content (DLCactual) and drug loading efficiency (DLE) were 
calculated from equations (1) - (3), respectively. The DLCactual is 
an average value from three measurements. For measurement of 
DLCactual, freeze-dried samples of drug-loaded nanospheres were 
dissolved in dichloromethane. The weight of actual drug 
entrapped in the dried nanospheres was determined by UV-Vis 
spectrophotometry (Perkin-Elmer Lambda 25) at 319 nm 
compared to standard curve of indomethacin. 
 
DLCtheoretical (%)   =   
100
copolymer and drug feed of Weights
 drug feed ofWeight 
´       (1) 
 
DLCactual (%)   =   
100
snanosphere loaded-drug ofWeight 
 snanospherein  entrapped drug actual ofWeight 
´
            (2) 
 
DLE (%) = 100
DLC
DLC
ltheoretica
actual ´                            (3) 
 
In vitro Drug Release Test 
In vitro drug release test of the drug-loaded nanospheres was 
performed in a phosphate buffer solution (PBS, 0.1 M, pH 7.4). 
Two mL of nanosphere suspension was put in a dialysis bag 
(molecular weight cut-off = 8,000 – 12,000 Da), and immersed 
into a flask containing 150 mL of release medium, PBS. The flask 
was placed in an incubator shaker at 37 °C. At predetermined 
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time interval, 10 mL of release medium was withdrawn, and 10 
mL of fresh PBS was re-placed into the flask for continuing the 
release test. The released indomethacin was measured by an UV-
Vis spectrophotometer at 319 nm. According to a predetermined 
indomethacin concentration-UV absorbance standard curve, 
indomethacin concentration of the release medium was obtained. 
Percentage of indomethacin release was calculated based on 
ratio of drug release in each releasing time and initial drug content 
in nanospheres. The average %release was calculated from the 
three measurements. 
Results and Discussion 
Characterization of Diblock Copolymers 
MPEG-b-PDLLGCL copolymers were synthesized from D,L-
lactide (DLL), glycolide (G) and e-caprolactone (CL) monomers in 
the presence of MPEG and stannous octoate. The hydroxyl end 
group of MPEG initiated the ring-opening of these monomers. 
Chemical compositions of the copolymers were determined from 
the 1H-NMR spectra by ratioing the peak areas corresponding to 
the ethylene oxide (EO) methylene protons at d = 3.4-3.6 ppm 
(repeating units of MPEG block), the DLL methine protons at d = 
5.0-5.3 ppm, the G methylene protons at d = 4.5-4.9 ppm and the 
CL e-methylene protons at d = 3.9-4.2 ppm. The 1H-NMR spectra 
of the copolymers are shown in Figure 1 and the copolymer 
compositions of EO/DLL/G/CL and DLL/G/CL (mol %) calculated 
from 1H-NMR spectra are summarized in Table 1. As would be 
expected, the copolymer compositions are similar to the 
comonomer feed ratios, indicating that the synthesis reactions 
proceeded to near-quantitative conversion. The nM s calculated 
from 1H-NMR spectra are also reported in Table 1. It can be seen 
that the nM s of copolymers calculated from 1H-NMR spectra are 
similar calculated from the feed ratio.  
Thermal transition properties of the copolymers were carried out 
by means of differential scanning calorimetry (DSC). The MPEG 
shows a melting temperature (Tm) at 56 oC. The DSC curves of 
the copolymers exhibited only glass transition temperatures (Tg) 
in range of 22 - 37 oC but did not Tm, as summarized in Table 2. It 
is significant to note that the crystallizability of the MPEG blocks in 
all copolymers was suppressed as connected to the amorphous 
polyester blocks. The Tg of the copolymers significantly 
decreased when glycolide and e-caprolactone units were 
incorporated into the polyester chain.  
Characterization of Nanospheres 
The drug-loaded nanospheres were prepared by the modified-
SESD method without any emulsifiers. The nanospheres were 
solidified after ethanol and acetone diffused out from emulsion 
droplets to continuous water phase. The MPEG blocks attached 
to PDLLGCL blocks can act as the emulsifier to prevent 
nanoparticle aggregation [12]. 
The morphology of nanospheres was investigated from TEM 
micrographs, as shown in Figure 2. The nanospheres had a 
nearly spherical shape and smooth in surfaces. The nanoparticles 
are in nanometer size range. The average sizes of nanospheres 
determined by the light-scattering method are summarized in 
Table 3. Their average sizes were found in range of 126 - 134 nm 
with narrow size distribution. Figure 3 shows an example of LS 
particle size graph. The results suggested that the DLL/G/CL 
ratios did not affect morphology and average size of the drug-
loaded nanospheres. 
The indomethacin drug is a crystalline drug that have a melting 
temperature about 155 °C. However, the melting peak of 
indomethacin entrapped in the nanospheres did not be detected 
from DSC thermograms of drug-loaded nanospheres. The results 
showed that the indomethacin crystallizability in the drug-loaded 
nanospheres was suppressed. This suggested that the drug was 
homogeneous dispersed in an amorphous state inside the 
nanosphere matrix. The indomethacin entrapped in the 
nanospheres can decrease slightly the Tg of copolymer 
nanosphere matrix, as reported in Table 2. This may be explained 
that the drug molecules entrapped in the copolymer matrix 
increase the copolymer molecule’s free volume. 
The calculated DLCactual and DLE values are also summarized in 
Table 3. The DLCactual and DLE of drug-loaded nanospheres are 
approximately 3% and 30%, respectively. This indicated that the 
partial drug has diffused out during the nanosphere formation. 
The different DLL/G/CL ratios did not affect the drug loading of 
nanospheres. 
In vitro Drug Release 
The in vitro drug release profiles of the nanospheres in PBS, pH 
7.4 at 37 °C for 7 days are illustrated in Figure 4. The drug 
release profiles show biphasic containing rapid initial burst release 
and sustaining release. The rapid initial burst release of drug from 
the nanospheres was probably due to the releasing of drug that 
entrapped or adsorbed near to the nanosphere surfaces. After 
that the slow release may be due to drug diffusion mechanism. 
The initial burst releases from the nanospheres were found within 
the first 12 h of release time. Then, release profiles were followed 
by a constant slow release until to 62, 79 and 88% indomethacin 
release within 7 days for DLL/G/CL ratios of 100/0/0, 80/20/0 and 
80/15/5 mol%, respectively. The drug release results indicated 
that the DLL/G/CL ratio was an important factor of the drug 
release behavior. The results may be explained that the lower Tg 
nanosphere matrix exhibited higher drug releasing. The drug can 
easier diffuse out for the lower Tg nanosphere matrix.  
Conclusions 
In present work, the nanospheres were prepared from 
synthesized MPEG-b-PDLLGCL by the modified-SESD method 
for controlled-release of a poorly water-soluble model drug, 
indomethacin. The drug-loaded nanospheres were of size about 
130 nm with narrow size distribution. The drug-loaded 
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nanospheres had nearly spherical in shape and smooth in 
surface. The DLL/G/CL ratios did not influence on the average 
size, shape and DLE of the drug-loaded nanospheres. The drug 
release content from copolymer nanospheres are in order 
DLL/G/CL of 80/15/5 > 80/20/0 > 100/0/0 mol%. The drug release 
rate can be optimally controlled by adjusting the DLL/G/CL ratios 
of MPEG-b-PDLLGCL nanosphere matrix. These nanospheres 
may have potential to provide other poorly water-soluble drugs for 
controlled-release drug delivery applications. 
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Table. 1. Copolymer composition and Mn of the MPEG-b-PDLLGCL. 
 
 
DLL/G/CL 
 
EO/DLL/G/CL ratio 
(mol %) 
DLL/G/CL ratio 
(mol %) 
nM  (g/mol) 
Feed ratioa 1H NMRb Feed ratioa 1H NMRb Feed ratioa 1H-NMRc 
100/0/0 
80/20/0 
80/15/5 
22/78/0/0 
21/63/16/0 
21/63/12/4 
21/79/0/0 
21/67/12/0 
20/66/10/4 
100/0/0 
80/20/0 
80/15/5 
100/0/0 
85/15/0 
83/12/5 
65,000 
65,000 
65,000 
67,700 
65,000 
67,300 
a Calculated from comonomer feed ratios 
b Calculated from 1H-NMR spectra 
c Calculated from EO/DLL/G/CL ratio (1H-NMR spectra) 
 
 
 
Table. 2. Glass transition temperatures (Tg) of the copolymers and drug-loaded copolymer 
nanospheres. 
 
DLL/G/CL ratio  
(mol%) 
Tga  
(oC) 
Copolymers 
       100/0/0 
       80/20/0 
       80/15/5 
Nanospheres 
       100/0/0 
       80/20/0 
       80/15/5 
 
37 
28 
22 
 
35 
25 
21 
a Mid-point of DSC glass transition from DSC curves 
 
 
 
 
Table. 3. Average particle size and drug loading of the drug-loaded copolymer nanospheres. 
 
DLL/G/CL ratio  
(mol%) 
Average particle sizea 
(nm) 
DLCactualb  
(%) 
DLEc  
(%) 
100/0/0 
80/20/0 
80/15/5 
126 ± 15 
134 ± 18 
129 ± 15 
2.8 
3.1 
2.6 
28 
31 
26 
a obtained from light-scattering analysis 
b calculated from equation (2) 
c calculated from equation (3); DLCtheoretical = 10% 
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Figure 1 1H-NMR spectra of MPEG-b-PDLLGCL with DLL/G/CL ratios of (a) 100/0/0, (b) 
80/20/0 and (c) 80/15/5 mol% (Peak assignments as shown). 
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Figure 2 TEM micrographs of drug-loaded nanospheres with DLL/G/CL ratios of (a) 100/0/0, 
(b) 80/20/0 and (c) 80/15/5 mol% (All bars = 100 nm). 
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Figure 3 Light-scattering (LS) particle size graph of MPEG-b-PDLLGCL nanospheres with 
DLL/G/CL ratio of 80/15/5 mol%. 
 
 
 
 
Figure 4 In vitro drug release profile from diblock copolymer nanospheres with DLL/G/CL 
ratios of (▲) 100/0/0, (■) 80/20/0 and (t) 80/15/5 mol%. 
